维普期刊资源整合服务平台（V6.5）

129篇 您的检索式：作者名="GOke B"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin resistant subjects显示文摘	Nagel JM Tietz AB Goke B	2006	Metabolism2006，55，9：	1
2	Glueagon - like peptide - 1 promotes satiety and reduces food in take in patients with diabetes mellitus type 2 显示文摘	Gutzwiller JP Drewe J Goke B	1999	Am J Physiol Regul lntegr Comp Physiol1999，276，：	1
3	Regulation of TRAIL-induced apoptosis by transcription factors 显示文摘	Goke R Goke A Goke B	2000	Cell Immunol2000，201，：	1
4	Ligand-induced regulation of glucagon-like peptide- Ⅰ receptor function and expression in insulin-secreting beta cells显示文摘	Fehmann HC Jiang J Pitt D Schweinfurth J Goke B	1996	Pancreas1996，13，3：	1
5	Glucagon-like peptide-1(7-36) amide is a new ineretin/enterogastrone candidate显示文摘	Goke R Fehmann H C Coke B	1991	Eur J Clin Invest1991，21，：	1
6	Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis 显示文摘	Kolligs F T Bommer G Goke B	2002	Diges- tion2002，66，3：	1
7	Regulation of TRAILinduced apoptosis by transcription factors显示文摘	Goke R Goke A Goke B	2000	Cell Immunol2000，201，2：	1
8	Wnt/β-catenin /Tcf signaling: A critical pathway in gastrointestinal tumorigenesis 显示文摘	Kolligs F T Bomer G Goke B	2002	Digestion2002，66，3：	1
9	Saxagliptin is non-inferior to giipizide in patients with type 2 diabetes mel显示文摘	GOKE B GALLWITZ B ERIKSSON J	2010	Int J Clin Pratt2010，64，12：	1
10	Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone:a 52-week randomised controlled trial显示文摘	Goke B Gallwitz B Eriksson J	2010	Int J Clin Pract2010，64，12：	1
11	Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2显示文摘	Gutzwiller JP Drewe J Goke B	1999	Am J Physiol Regul Integr Comp Physiol1999，276，52：	1
12	Stress kinase inhibition modulates acute experimental pancreatitis 显示文摘	FLEISCHAR F DABEW R GOKE B	2002	World J Gastroenterol2002，8，：	1
13	Glucagon-like peptide-1 promotes satiety and reduces food intake patients with diabetes mellitus type 2显示文摘	Drewe J Goke B	1999	Am J Physiol1999，276，5：	1
14	Type 2 diabetes mellitus as risk factor for colorectal cancer 显示文摘	Berster JM Goke B	2008	Arch Physiol Biochem2008，114，1：	1
15	The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation显示文摘	LANKAT-BUTTGEREIT B GOKE R	2009	Biol Cell2009，101，：	1
16	Glucagonlike peptide-1(7-36) amide is a new incretin/enterogastrone candidate显示文摘	Goke R Fehmann H C Goke B	1991	Eur J Clin Invest1991，21，2：	1
17	Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mel-litus inadequately controlled on metformin alone:A 52-week randomised controlled trial显示文摘	Goke B Gallwitz B Eriksson J	2010	International Journalof Clinical Practice2010，64，12：	1
18	Cell and molecular biology of the ineretin hormones glueagon-like peptide-Ⅰ and glucose-dependent insulin releasing polypeptide显示文摘	Fehmann HC Goke R Goeke B	1995	Endocr Rev1995，16，3：	1
19	Detection of the human glueagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes显示文摘	Lankat-Buttgereit B Goke R Stockmann F	1994	Digestion1994，55，1：	1
20	The tumour suppressor Pdcd4:recent advances in the elucidation of function and regulation显示文摘	Lankat-Buttgereit B Goke R	2009	Biol Cell2009，101，6：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示